BIPOLAR II DISORDER
Clinical trials for BIPOLAR II DISORDER explained in plain language.
Never miss a new study
Get alerted when new BIPOLAR II DISORDER trials appear
Sign up with your email to follow new studies for BIPOLAR II DISORDER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Ketamine infusions show promise for tough-to-treat bipolar depression
Disease control CompletedThis study looked at whether repeated ketamine infusions can help people with bipolar depression who did not get better with other treatments. 41 adults who already responded to an initial course of ketamine received up to 6 more infusions over 12 weeks. The goal was to see if th…
Matched conditions: BIPOLAR II DISORDER
Phase: PHASE2 • Sponsor: Joshua Rosenblat • Aim: Disease control
Last updated May 26, 2026 11:21 UTC
-
Ketamine shows promise for bipolar depression in new trial
Symptom relief CompletedThis study tested whether repeated doses of intravenous ketamine can safely and effectively reduce depression in people with bipolar disorder who haven't responded to other treatments. 71 adults with bipolar I or II and current major depression received four ketamine infusions or…
Matched conditions: BIPOLAR II DISORDER
Phase: PHASE2 • Sponsor: Joshua Rosenblat • Aim: Symptom relief
Last updated May 26, 2026 11:16 UTC
-
New pill aims to lift bipolar depression in 6 weeks
Symptom relief CompletedThis study tested an experimental drug called ABBV-932 in 161 adults with bipolar I or II disorder who were currently experiencing a depressive episode. Participants took either the drug or a placebo daily for 6 weeks to see if it safely improves mood and reduces depression sympt…
Matched conditions: BIPOLAR II DISORDER
Phase: PHASE2 • Sponsor: AbbVie • Aim: Symptom relief
Last updated May 18, 2026 12:08 UTC
-
New at-home pill aims to calm agitation from schizophrenia and bipolar disorder
Symptom relief CompletedThis study tested an investigational medication called BXCL501 for calming agitation episodes in people with bipolar disorder, schizophrenia, or related conditions. 452 participants received either the drug or a placebo, and researchers measured changes in agitation levels and sa…
Matched conditions: BIPOLAR II DISORDER
Phase: PHASE3 • Sponsor: BioXcel Therapeutics Inc • Aim: Symptom relief
Last updated May 18, 2026 12:04 UTC
-
Can family members help measure agitation? new study says maybe
Knowledge-focused CompletedThis study looked at whether family members or caregivers can help measure agitation in people with bipolar disorder or schizophrenia. 33 adults took a single dose of an experimental medicine, and researchers compared ratings from doctors, patients, and their family members. The …
Matched conditions: BIPOLAR II DISORDER
Phase: PHASE2 • Sponsor: BioXcel Therapeutics Inc • Aim: Knowledge-focused
Last updated Apr 26, 2026 20:01 UTC